AUG 6, 2026 · PHASE 3 TRIAL
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
ClinicalTrials.gov
This is a clinical trial registry record for a Phase 3 study that is actively recruiting; no results are reported, making this a description of planned research rather than evidence of efficacy or safety.
Reported
Planned enrollment800
Study phasePhase 3
Primary outcome measureChange from baseline to Week 72 in Clinical…